Dubé LM - Search Results

1

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.

Liu MC, Dubé LM, Lancaster J. Liu MC, et al. Among authors: dube lm. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 1):859-71. doi: 10.1016/s0091-6749(96)80002-9. J Allergy Clin Immunol. 1996. PMID: 8939149 Free article. Clinical Trial.

2

Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.

DuBuske LM, Grossman J, Dubé LM, Swanson LJ, Lancaster JF. DuBuske LM, et al. Among authors: dube lm. Am J Manag Care. 1997 Apr;3(4):633-40. Am J Manag Care. 1997. PMID: 10169531 Free article. Clinical Trial.

3

A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis.

Hawkey CJ, Dube LM, Rountree LV, Linnen PJ, Lancaster JF. Hawkey CJ, et al. Among authors: dube lm. Gastroenterology. 1997 Mar;112(3):718-24. doi: 10.1053/gast.1997.v112.pm9041232. Gastroenterology. 1997. PMID: 9041232 Clinical Trial.

4

A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group.

Schwartz HJ, Petty T, Dubé LM, Swanson LJ, Lancaster JF. Schwartz HJ, et al. Among authors: dube lm. Arch Intern Med. 1998 Jan 26;158(2):141-8. doi: 10.1001/archinte.158.2.141. Arch Intern Med. 1998. PMID: 9448552 Clinical Trial.

5

Safety and clinical efficacy of zileuton in patients with chronic asthma.

Lazarus SC, Lee T, Kemp JP, Wenzel S, Dubé LM, Ochs RF, Carpentier PJ, Lancaster JF. Lazarus SC, et al. Among authors: dube lm. Am J Manag Care. 1998 Jun;4(6):841-8. Am J Manag Care. 1998. PMID: 10181070 Free article. Clinical Trial.

6

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics.

Hasday JD, Meltzer SS, Moore WC, Wisniewski P, Hebel JR, Lanni C, Dubé LM, Bleecker ER. Hasday JD, et al. Among authors: dube lm. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1229-36. doi: 10.1164/ajrccm.161.4.9904026. Am J Respir Crit Care Med. 2000. PMID: 10764316 Clinical Trial.

7

Zileuton, a leukotriene synthesis inhibitor in the management of chronic asthma. Clinical pharmacokinetics and safety.

Dubé LM, Swanson LJ, Awni W. Dubé LM, et al. Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):213-21. doi: 10.1007/BF02737605. Clin Rev Allergy Immunol. 1999. PMID: 10436867 Review. No abstract available.

8

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

Nelson H, Kemp J, Berger W, Corren J, Casale T, Dube L, Walton-Bowen K, LaVallee N, Stepanians M. Nelson H, et al. Ann Allergy Asthma Immunol. 2007 Aug;99(2):178-84. doi: 10.1016/S1081-1206(10)60642-4. Ann Allergy Asthma Immunol. 2007. PMID: 17718106 Clinical Trial.

9

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.

Israel E, Cohn J, Dubé L, Drazen JM. Israel E, et al. JAMA. 1996 Mar 27;275(12):931-6. JAMA. 1996. PMID: 8598621 Clinical Trial.

10

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE. Dahlén B, et al. Among authors: dube lm. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1187-94. doi: 10.1164/ajrccm.157.4.9707089. Am J Respir Crit Care Med. 1998. PMID: 9563738 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page